Q2 2017
Released Aug 8, 2017, after the close
10-Q filed Aug 8, 2017, 39 days after period end · 0001493152-17-008653
Q2 2017 · 10-Q
Revenue$859.00K$859.00K +68.8% vs Q2 2016+17.0% vs Q1 2017
Net Income-$786.00K-$786.00K N/M vs Q2 2016N/M vs Q1 2017
EPS Diluted-$0.01-$0.01 N/M vs Q2 2016N/M vs Q1 2017
Gross Profit$517,000+74.1%
Operating Income-$700,000N/M
Operating Cash Flowderived-$499,000N/M
Margins · derived
Gross margin60.2%+1.8 pt vs Q2 2016
Operating margin-81.5%+79.0 pt vs Q2 2016
Net margin-91.5%+72.5 pt vs Q2 2016
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $859.00K | $509.00K | $567.00K | $441.00K |
| Net Income | -$786.00K | -$835.00K | -$1.82M | -$5.34M |
| EPS Diluted | -$0.01 | -$0.02 | -$0.06 | -$0.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR